The role of α5-nicotinic acetylcholine receptor/NLRP3 signaling pathway in lung adenocarcinoma cell proliferation and migration
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of α5-nicotinic acetylcholine receptor/NLRP3 signaling pathway in lung adenocarcinoma cell proliferation and migration
Authors
Keywords
α5-nicotinic acetylcholine receptor, STAT3, NLRP3 inflammasome, Cell proliferation, Cell migration, Lung adenocarcinoma
Journal
TOXICOLOGY
Volume 469, Issue -, Pages 153120
Publisher
Elsevier BV
Online
2022-02-05
DOI
10.1016/j.tox.2022.153120
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NLRP3 inflammasome in cancer and metabolic diseases
- (2021) Bhesh Raj Sharma et al. NATURE IMMUNOLOGY
- Neurodegenerative Disease and the NLRP3 Inflammasome
- (2021) Jonathan A. Holbrook et al. Frontiers in Pharmacology
- Dynamic Immune/Inflammation Precision Medicine: The Good and the Bad Inflammation in Infection and Cancer
- (2021) Jean-François Rossi et al. Frontiers in Immunology
- NLRP3-mediated pyroptosis aggravates pressure overload-induced cardiac hypertrophy, fibrosis, and dysfunction in mice: cardioprotective role of irisin
- (2021) Rongchuan Yue et al. Cell Death Discovery
- Lung health, tobacco, and related products: gaps, challenges, new threats, and suggested research
- (2020) Simone St Claire et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Smoking, air pollution, and lung cancer risk in the Nurses’ Health Study cohort: time-dependent confounding and effect modification
- (2020) Ellen T. Chang et al. CRITICAL REVIEWS IN TOXICOLOGY
- Discovery of new fluorescent thiazole–pyrazoline derivatives as autophagy inducers by inhibiting mTOR activity in A549 human lung cancer cells
- (2020) ZhaoMin Lin et al. Cell Death & Disease
- Pyroptosis is involved in the inhibitory effect of FL118 on growth and metastasis in colorectal cancer
- (2020) Zhenxue Tang et al. LIFE SCIENCES
- Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
- (2019) Yang Yang et al. Cell Death & Disease
- Activation of α7‐nAChRs protects SH‐SY5Y cells from 1‐methyl‐4‐phenylpyridinium‐induced apoptotic cell death via ERK/p53 signaling pathway
- (2019) Shi Xu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Alpha7 nicotinic acetylcholine receptors in lung inflammation and carcinogenesis: Friends or foes?
- (2019) Khalil Hajiasgharzadeh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Prevention and Early Detection for NSCLC: Advances in Thoracic Oncology 2018
- (2019) Haval Balata et al. Journal of Thoracic Oncology
- CHRNA3 rs1051730 and CHRNA5 rs16969968 polymorphisms are associated with heavy smoking, lung cancer, and chronic obstructive pulmonary disease in a mexican population
- (2018) Rebeca Pérez-Morales et al. ANNALS OF HUMAN GENETICS
- Chick Embryo: A Preclinical Model for Understanding Ischemia-Reperfusion Mechanism
- (2018) Eram Fauzia et al. Frontiers in Pharmacology
- Acetylcholine signaling system in progression of lung cancers
- (2018) Jamie R. Friedman et al. PHARMACOLOGY & THERAPEUTICS
- Reciprocal activation of α5-nAChR and STAT3 in nicotine-induced human lung cancer cell proliferation
- (2017) Yao Zhang et al. Journal of Genetics and Genomics
- Myocyte enhancer factor 2D provides a cross-talk between chronic inflammation and lung cancer
- (2017) Hai-xing Zhu et al. Journal of Translational Medicine
- Alpha5 Nicotinic Acetylcholine Receptor Contributes to Nicotine-Induced Lung Cancer Development and Progression
- (2017) Hai-Ji Sun et al. Frontiers in Pharmacology
- Inflammasomes in Inflammation-Induced Cancer
- (2017) Chu Lin et al. Frontiers in Immunology
- TheCHRNA5/CHRNA3/CHRNB4Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations
- (2016) Elizabeth S. Barrie et al. HUMAN MUTATION
- Activation of NLRP3 inflammasome enhances the proliferation and migration of A549 lung cancer cells
- (2016) YANLI WANG et al. ONCOLOGY REPORTS
- Smokers are less likely than non-smokers to seek help for a lung cancer ‘alarm’ symptom
- (2016) C Friedemann Smith et al. THORAX
- Nicotinic cholinergic receptors in esophagus: Early alteration during carcinogenesis and prognostic value
- (2016) Marina Chianello Nicolau et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes — A Meta-Analysis
- (2016) Li-Shiun Chen et al. EBioMedicine
- The Oncogenic Functions of Nicotinic Acetylcholine Receptors
- (2016) Yue Zhao Journal of Oncology
- α5-nAChR modulates nicotine-induced cell migration and invasion in A549 lung cancer cells
- (2015) Haiji Sun et al. EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
- Recent progress in revealing the biological and medical significance of the non-neuronal cholinergic system
- (2015) Sergei A. Grando et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Contribution of Variants in CHRNA5/A3/B4 Gene Cluster on Chromosome 15 to Tobacco Smoking: From Genetic Association to Mechanism
- (2014) Li Wen et al. MOLECULAR NEUROBIOLOGY
- Alpha5 nicotinic acetylcholine receptor mediates nicotine-induced HIF-1α and VEGF expression in non-small cell lung cancer
- (2014) Xiaoli Ma et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started